Tag: COVID-19 vaccine

April 20, 2022 Off

Moderna: Clinical update on bivalent COVID-19 booster platform

By Author

Moderna has announced new clinical data on its bivalent COVID-19 booster platform including data on the company’s first bivalent booster candidate, mRNA-1273.211, which includes mutations found in the Beta variant of concern, several of which have been persistent in more recent variants of concern including Omicron.

April 14, 2022 Off

Valneva’s Inactivated Covid-19 Vaccine Gets CMA in UK

By Author

The Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom has granted Conditional Marketing Authorization (CMA) for Valneva’s inactivated whole-virus COVID-19 vaccine candidate, VLA2001, for primary immunization in adults 18 to 50 years of age.